# Chris Twelves

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/chris-twelves/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,552 |
| Field | Cancer Treatment and Pharmacology |
| h-index | 57 |
| i10-index | 146 |
| Last Known Institution | University of Leeds |
| OpenAlex ID | https://openalex.org/A5021317857 |
| ORCID iD | https://orcid.org/0000-0002-1849-7153 |
| Works | 325 |

## Researcher papers

- [Doxorubicin and Paclitaxel Versus Doxorubicin and Cyclophosphamide as First-Line Chemotherapy in Metastatic Breast Cancer: The European Organization for Research and Treatment of Cancer 10961 Multicenter Phase III Trial](https://scholariq.org/papers/doxorubicin-and-paclitaxel-versus-doxorubicin-and-cyclophosphamide-as-first-line/)

## Researcher topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Researcher university

- [University of Leeds](https://scholariq.org/institutions/university-of-leeds/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.